¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"leukocyte bactericidal assay test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • clearance test
    û¼ÒÀ²½ÃÇè
  • clock-drawing test
    ½Ã°è±×¸®±â°Ë»ç
  • cold pressure test
    ÇÑ·©¾Ð¹Ú°Ë»ç
  • complement fixation inhibition test
    º¸Ã¼°áÇÕ¾ïÁ¦°Ë»ç
  • complement fixation test
    º¸Ã¼°áÇÕ°Ë»ç
  • contraction stress test
    ¼öÃàÀڱذ˻ç
  • Coombs¡¯ test
    ÄñÁî°Ë»ç
  • coordination test
    ¼Õ¹ßÇùÁ¶±â´É°Ë»ç
  • cover-uncover test
    °¡¸²¾È°¡¸²°Ë»ç
  • creatinine clearance test
    Å©·¹¾ÆÆ¼´Ñû¼ÒÀ²°Ë»ç
  • catalase test
    īŻ¶ó¾ÆÁ¦°Ë»ç
  • challenge test
    À¯¹ß°Ë»ç
  • caloric test
    ¿Â¼ö´«¶³¸²°Ë»ç
  • chemiluminescence test
    È­Çй߱¤°Ë»ç
  • chi-square test
    Ä«ÀÌÁ¦°ö°ËÁ¤
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • bleeding time test
    ÃâÇ÷½Ã°£°Ë»ç
  • blocking test
    Â÷´Ü½ÃÇè
  • blood test
    Ç÷¾×°Ë»ç
  • blood coagulation test
    Ç÷¾×ÀÀ°í°Ë»ç
  • blood sugar test
    Ç÷´ç°Ë»ç
  • bone conduction test
    »ÀÀüµµ°Ë»ç, °ñµµ°Ë»ç
  • bone marrow function test
    °ñ¼ö±â´É°Ë»ç
  • breath holding test
    È£ÈíÁßÁö½ÃÇè, È£ÈíÁßÁö°Ë»ç
  • bulbocavernous evoked-response test
    ¸Á¿ïÇØ¸éü±ÙÀ¯µµ¹ÝÀÀ°Ë»ç
  • bulbocavernous reflex latency test
    ¸Á¿ïÇØ¸éü±Ù¹Ý»ç½Ã°£ÃøÁ¤°Ë»ç
  • caloric test
    ¿Âµµ´«¶³¸²°Ë»ç
  • carbohydrate tolerance test
    ź¼öÈ­¹°³»¼º½ÃÇè
  • carbon monoxide hemoglobin test
    ÀÏ»êȭź¼ÒÇì¸ð±Û·Îºó°Ë»ç
  • catalase test
    īŻ¶ó¾ÆÁ¦°Ë»ç
  • cell-mediated lympholysis test
    ¼¼Æ÷¸Å°³¸²ÇÁ±¸¿ëÇØ½ÃÇè
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • DNase test
    DNA ºÐÇØÈ¿¼Ò½ÃÇè
  • DST=dexamethasone supression test
    µ¦»ç¸ÞŸ¼Õ ¾ïÁ¦°Ë»ç
  • Dehydration test
    Å»¼ö°Ë»ç
  • Denver Developmental Screening Test
    µ§¹ö¹ß´ÞÁ¶»ç°Ë»ç(Û¡Ó¹ðàÞÛËþÞÛ)
  • Denver developmental screening test
    µ§¹ö¹ßÀ°¼±º°¹ý.
  • Dick test
    µñÅ©½ÃÇè
  • Dick test
    µñ °Ë»ç
  • Donath-Landsteiner test
    µµ³ª¾²¶õÆ®½ºÅ¸ÀÌ³Ê °Ë»ç
  • Draw-A-Person test(DAP)
    Àι°È­°Ë»ç
  • Du test
    Du °Ë»ç (ÁÖÀÇ : u ´Â À­Ã·ÀÚÀÓ)
  • Eleks gel-precipitin test
    ¿¤·ºÅ©ÇÑõÆòÆÇħ°­¹ý (µðÇÁÅ׸®¾Æµ¶¼Ò µ¿Á¤¹ý)
  • Farnworth D-15 test
    ÆÄ¸¥¿ö½º15»ö»ó°Ë»ç
  • Farnworth-Munsell 100 hue test
    ÆÄ¸¥¿ö½º-¹®¼¿ 100»ö»ó°Ë»ç
  • Freda test
    ÇÁ·¹´Ù½ÃÇè
  • Frei s test
    ÇÁ¶óÀ̽ÃÇè<¹ÝÀÀ>
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • broken leukocyte
    ±úÁø¹éÇ÷±¸
  • class I human leukocyte antigen
    Á¦ 1±Þ ÀÎü¹éÇ÷±¸Ç׿ø
  • class II human leukocyte antigen
    Á¦ 2±Þ ÀÎü¹éÇ÷±¸Ç׿ø
  • contracted leukocyte
    ¼öÃà¹éÇ÷±¸
  • differential leukocyte count
    °¨º°Ç÷±¸°è»ê<<¹éÇ÷±¸ÀÇ ¹éºÐÀ²>>
  • endothelial leukocyte
    ³»ÇǼº ¹éÇ÷±¸(?ËÑÌ´Ë´).
  • endothelial leukocyte adhesion molecule
    ³»ÇǼ¼Æ÷¹éÇ÷±¸ À¯ÂøºÐÀÚ
  • eosinophil leukocyte
    »êÈ£¼º ¹éÇ÷±¸(¡­ÛÜúìϹ).ÀÇÈ£»ê¼º ¹éÇ÷±¸.
  • eosinophil leukocyte
    »êÈ£¼º ¹éÇ÷±¸(?ËÑÌ´Ë´).[ÀÇ]È£»ê¼º ¹éÇ÷±¸.
  • eosinophilic leukocyte
    È£»ê¼º¹éÇ÷±¸
  • globular leukocyte
    ±¸»ó¹éÇ÷±¸(Ë´Ë×ËÑÌ´Ë´).
  • globule leukocyte
    µÕ±Ù°ú¸³¹é¼¼Æ÷
  • granular leukocyte
    °ú¸³¹éÇ÷±¸
  • heterophile leukocyte
    ÀÌ¿°¼º ¹éÇ÷__ì£æøàõÛÜúìϹ).
  • human leukocyte antigen
    Àΰ£ ¹éÇ÷±¸ Ç׿ø
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • ring test
    °í¸®½ÃÇè(ãËúÐ)
  • Rothera's test
    ·ÎÅ×¶ó ½ÃÇè(ãËúÐ)
  • Schiff's test
    ½¬ÇÁ ½ÃÇè(ãËúÐ)
  • Schilling test
    ½¯¸µ ½ÃÇè(ãËúÐ)
  • seliwanoff's test
    ¼¿¸®¹Ù³ëÇÁ ½ÃÇè(ãËúÐ)
  • SSA test
    SSA ½ÃÇè(ãËúÐ) (å²)
  • sulfosalicylic acid test
    ¼³Æ÷»ì¸®½Ç»ê(ß«)
  • Sulkowitch test
    ¼úÄÚºñÄ¡ ½ÃÇè(ãËúÐ)
  • suppression test
    ¾ï¾Ð ½ÃÇè(åääâãËúÐ)
  • test meal
    ½ÃÇè½Ä(ãËúÐãÝ)
  • thymol turbidity test
    ŸÀ̸ô ȥʵµ ½ÃÇè (ûèöúÓøãËúÐ)
  • Tollen's test
    Åç·» ½ÃÇè(ãËúÐ)
  • tryptophan load test
    Æ®¸³ÅäÆÇ ºÎÇϽÃÇè(ݶùÃãËúÐ)
  • t test
    t ½ÃÇè(ãËúÐ)
  • tuberculin test
    Åõº£¸£Ä𸰠°Ë»ç(ËþÞÛ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
MIT Massachusetts Institute of Technology; male impotence test; marrow iron turnover; melodic intonation...
PCT peripheral carcinoid tumor; plasma clotting time; plasmacrit test; plasmacytoma; polychlorinated tri...
SCAT sheep cell agglutination test; sickle cell anemia test; Sports Competition Anxiety Test
SCT secretin; sex chromatin test; sexual compatibility test; sickle-cell trait; sperm cytotoxicity; spin...
SIT serum inhibiting titer; Slosson Intelligence Test; sperm immobilization test; suggested immobilizati...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
C-ELISA Competitive enzyme-linked immunosorbent assay
DEIA DNA enzyme immuno assay
DIG-ELISA Diffusion-In-Gel Enzyme Linked Immunosorbent Assay
DFA Direct immunofluorescence assay
Dot-ELISA Dot Enzyme-Linked Immunosorbent Assay
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bile solubility test
    ´ãÁó ¿ëÇØ ½ÃÇè
  • bilirubin test
    ºô¸®·çºó ½ÃÇè
  • binaural distorted speech test
    ¾çÀÌ¿ÖÈ­ ½ÃÇè
  • Binet's test
    ºñ³× ½ÃÇè
    ¼Ò¾Æ¿Í û³âÀÇ Á¤½Å ´É·ÂÀ» °Ë»çÇÏ´Â ¹æ¹ýÀ¸·Î, °¢Á¾ ¿¬·É¿¡¼­ÀÇ Á¤»ó ¾Æµ¿ÀÇ ´É·Â¿¡ ÀûÇÕÇϰí Ç¥ÁØÈ­µÈ ÀÏ·ÃÀÇ Áú¹®À» ÇǰËÀÚ¿¡°Ô ÇÏ¿©, ÀÌ¿¡ ´ëÇÑ ´ë´ä¿¡ µû¶ó ÇǰËÀÚÀÇ Á¤½Å ¿¬·ÉÀ» °áÁ¤ÇÏ´Â °Í.
  • Bing test
    ºù ½ÃÇè
    Áøµ¿À½Â÷¸¦ À¯¾çµ¹±â À§¿¡ ³õ°í, ûµµ¸¦ ±³´ë·Î Æó¼âÇÏ¿´´Ù°¡ °³¹æÇÏ¿´´Ù°¡ ÇÑ´Ù. ¼Ò¸®ÀÇ ³ô°í ³·À½Àº Á¤»ó ±Í¿¡¼­ ûÃëµÇ¸ç, ¶ÇÇÑ Áö°¢½Å°æ¼º û°¢½Å°æ¼º û°¢Àå¾Ö¿¡¼­µµ µé¸®³ª, Àüµµ û°¢ Àå¾Ö¿¡¼­´Â ¼Ò¸®ÀÇ Â÷À̰¡ ¾øÀÌ µé¸°´Ù.
  • biuret test
    ¹ÙÀÌÀ¯·¿ ½ÃÇè
  • blank test
    °ø½ÃÇè
  • bleeding time test
    ÃâÇ÷ ½Ã°£ ½ÃÇè
  • blood sugar test
    Ç÷´ç °Ë»ç
  • blood test
    Ç÷¾× °Ë»ç, Ç÷¾× °Ë»ç¹ý
    Áúº´ÀÇ Áø´Ü, Ä¡·á ¹× ¿¹ÈÄ ÆÇÁ¤À» ¸ñÀûÀ¸·Î Ç÷¾×ÀÇ °¢Á¾ ¼ººÐÀ» °Ë»çÇÏ´Â ÀÏ. ¸ö ÀüüÀÇ Àå±â³ª Á¶Á÷¿¡ º´º¯ÀÌ ÀÖÀ¸¸é ÀÌµé ¼ººÐ¿¡ º¯È­°¡ ÀÖ°Ô µÇ¾î Áø´Ü¿¡ Å« µµ¿òÀ» ÁØ´Ù. ©ç ÇüÅÂÇÐÀû °Ë»ç¹ý : Ç÷¾×ÀÇ ¼¼Æ÷ÇÐÀû ¹× ÀÌÇÐÀûÀÎ ¼ºÁú°ú »óŸ¦ °Ë»çÇÏ´Â °ÍÀ¸·Î¼­ äÇ÷ÇÏ¿© ÀûÇ÷±¸ ¼ö, Ç÷»ö¼Ò·®, ÀûÇ÷±¸ ¿ëÀû°ú À̵鿡¼­ °è»êµÇ´Â °è¼ö¿Í ¹éÇ÷±¸ ¼ö, Ç÷¼ÒÆÇ ¼ö, ¸Á»ó ÀûÇ÷±¸ ¼ö µîÀ» °Ë»çÇÏ°í ¶Ç Ç÷¾× ÇÑ ¹æ¿ïÀ» ½½¶óÀÌµå ±Û¶ó½º¿¡ ¾ã°Ô ¹Ù¸¥ °ÍÀ» ¿°»öÇÏ¿© ¹éÇ÷±¸ÀÇ Á¾·ù, °¢Á¾ Ç÷±¸ÀÇ ÁúÀû º¯È­¸¦ Á¶»çÇÑ´Ù. ¶Ç ÃâÇ÷ ½Ã°£, ÀÀ°í ½Ã°£, ¸ð¼¼Ç÷°ü ÀúÇ× µîÀ» °Ë»çÇØ¼­ ÃâÇ÷ °æÇâ, Ç÷¾× Áúȯ, °¨¿°Áõ µîÀÇ Áø´Ü°ú °¢Á¾ ÁúȯÀÇ °æ°ú¿Í ¿¹ÈÄ ÆÇÁ¤¿¡ Å« µµ¿òÀÌ µÈ´Ù. ©è »ýÈ­ÇÐÀû °Ë»ç¹ý : Ç÷¾× ¼ÓÀÇ ¿©·¯ ¼ººÐÀ» »ýÈ­ÇÐÀû ¹æ¹ýÀ¸·Î ÃøÁ¤ÇÏ´Â °ÍÀ¸·Î Ç÷û ´Ü¹éÁú
  • bone conduction test
    °ñÀüµµ ½ÃÇè
  • Bonsignore test
    º»½Ã±×³ë ½ÃÇè
  • bracelet test
    ¿Ï·û ½ÃÇè
  • breakdown test
    ÆÄ±« ½ÃÇè
  • breath holding test
    È£Èí ÁßÁö ½ÃÇè
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
factor ix assay A test used to measure the activity of a blood clotting factor IX (Christmas factor). This test may be used to evaluate excessive bleeding. Abnormally low factor IX assays may be seen in the following conditions: congenital deficiency of factor IX, fat malabsorption, heparin administration, cirrhosis, vitamin K deficiency and warfarin administration.
(27 Sep 1997)
factor v assay A test used to measure the activity of a blood clotting factor V. This test may be used to evaluate excessive bleeding. Abnormally low factor V assays may be seen in the following conditions: congenital deficiency of factor V, DIC, heparin administration, cirrhosis and primary fibrinolysis.
(27 Sep 1997)
factor vii assay A test used to measure the activity of a blood clotting factor VII. This test may be used to evaluate excessive bleeding. Abnormally low factor VII assays may be seen in the following conditions: congenital deficiency of factor VII, fat malabsorption, heparin administration, cirrhosis, vitamin K deficiency and warfarin administration.
(27 Sep 1997)
factor viii assay A test used to measure the activity of a blood clotting factor VIII (Von Willebrand factor). This test is usually used to monitor treatment of haemophilia. Abnormally low factor VIII assays may be seen in the following conditions: congenital deficiency of factor VIII (haemophilia), DIC and secondary fibrinolysis. This test may also be performed in the evaluation of Von Willebrand's disease.
(27 Sep 1997)
factor x assay A test used to measure the activity of a blood clotting factor X. This test may be used to evaluate excessive bleeding. Abnormally low factor X assays may be seen in the following conditions: congenital deficiency of factor X, fat malabsorption, heparin administration, cirrhosis, vitamin K deficiency and warfarin administration.
(27 Sep 1997)
factor xii assay A test used to measure the activity of a blood clotting factor XII. This test may be used to evaluate excessive bleeding. Low factor XII may be seen in cases of congenital deficiency of factor XII, heparin administration and liver disease.
(27 Sep 1997)
Farr type assay <investigation> Method of radioimmunoassay in which free antigen remains soluble and antibody antigen complexes are precipitated.
(18 Nov 1997)
focus-forming assay <investigation> A lab technique used to find out if a particular piece of DNA contains oncogenes (genes which are associated with cancer).
This is done by putting the DNA into animal cells which normally show contact inhibition, or which stop growing when they come into physical contact with other cells or reach a certain density in the culture.
If the cells lose contact inhibition and form areas of densely-packed cells (called foci) after receiving the DNA, it means that the DNA did contain oncogenes.
(05 Jan 1997)
LH assay A blood test which measures the amount of luteinising hormone (LH). LH is a protein hormone that is secreted by the anterior pituitary gland. In women, a surge in LH at midcycle causes ovulation. For the next 7-10 days LH maintains the corpus luteum which synthesises progesterone. The corpus luteum disintegrates after about 10 days if fertilization does not occur. In men, LH stimulates production of testosterone by the Leydig cells in the testes. This test may be used to evaluate anovulatory bleeding, infertility, ovarian cysts and multiple endocrine neoplasia (MEN) I. Normal values in males: 7 to 24 U/L. Normal values in females: greater than 6-30 U/L. Greater than normal values can indicate: anorchia, hypogonadism, Klinefelter syndrome, menopause, ovarian failure, polycystic ovary disease, precocious puberty and Turner's syndrome. Lower than normal values can indicate hypopituitarism.
(27 Sep 1997)
Lowry-Folin assay A method for determining protein concentrations using the Folin-Ciocalteu reagent.
Synonym: Lowry-Folin assay.
(05 Mar 2000)
Lowry protein assay A method for determining protein concentrations using the Folin-Ciocalteu reagent.
Synonym: Lowry-Folin assay.
(05 Mar 2000)
Abbe test plate <equipment> A long, wedge-shaped coverslip about 0.20 mm thick at one end and 0.10 to 0.12 mm at the other end coated chemically with a silver film on which are ruled horizontal lines.
at each variation in thickness of 0.01 mm there are vertical lines. By means of oblique illumination and by focusing on different portions of the plate, it is possible to determine the optimum coverslip thickness for any objective and also, for microscopes with drawtubes, the tube length for best objective performance. The approximate freedom from spherical and chromatic aberrations can also be estimated. Small isolated bits of silver near the edges of the lines form good objects for the star test
(05 Aug 1998)
acetone test A test for ketonuria; the suspected urine is shaken up with a few drops of sodium nitroprusside, and strong ammonia water is then gently poured over the mixture; if acetone is present, a magenta ring forms at the line of contact; tablets containing sodium nitroprusside and alkali are now more commonly used.
(05 Mar 2000)
achievement test A standardised test used to measure acquired learning, e.g., competence in a specific subject area such as reading or arithmetic, in contrast to an intelligence test which is a useful index of potential ability or learning.
(05 Mar 2000)
acidified serum test Lysis of the patient's red cells in acidified fresh serum, specific for paroxysmal nocturnal haemoglobinuria.
Synonym: Ham's test.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á